The first decision in a research peptide business isn’t your supplier or your logo. It’s whether you’re genuinely going to run it as research-use-only, because the FDA has spent the last two years sending warning letters to sellers who printed “research use only” on the label and sold for human use everywhere else.
That’s the uncomfortable part, and it shapes everything below. How to start a peptide business that survives its first processor review comes down to eight jobs done in the right order. Most founders do them backwards: site first, payments last, lawyer never. Here’s the order we’d use, with rough timelines, the cash you’ll need that nobody mentions, and the things we’d skip in year one.
A note on who this is for. If you’re a clinic or telehealth brand prescribing through a licensed pharmacy, your path is different (licensure, prescriptions, LegitScript Healthcare Certification) and most of the research-use-only material here doesn’t apply to you. This post is for research suppliers.
How to start a peptide business: the steps in order
Here’s the order we’d follow. Once steps 1 and 2 are done, several of the others run in parallel.
Step 1: decide whether you can run a real research-use-only business
Research-use-only (RUO) isn’t a phrase you add to a footer. It’s a description of who you sell to and how you behave, and regulators and processors test it against everything else you do.
The FDA judges intended use objectively. Under 21 CFR 201.128, that includes “labeling claims, advertising matter, or oral or written statements” and the circumstances of the sale. The warning letters show how that plays out:
- Feb 2025: USAPeptide.com.
- Dec 12, 2025: Pinnacle Peptides. Labels said “FOR RESEARCH ONLY” and “NOT FOR HUMAN USE,” and FDA still found the products “intended to be drugs for human use.”
- Mar 31, 2026: Gram Peptides, where FDA said its evidence “establishes that your products are intended to be drugs for human use” despite the RUO labeling (the letter is public).
- Aug 24, 2026: a batch of letters to several peptide sellers. The evidence cited was website claims, dosing guidance, peptide reconstitution calculators, “peptide guides” and bacteriostatic water sold alongside. The letters were based on website review alone.
LegitScript’s Peptides for Payment Processors guide (Oct 2025) tells processors what to look for, and its red flags read like a description of the typical peptide store: a “Not for Human Consumption” disclaimer, no buyer-qualification step, a catalog made up mostly of commonly misused peptides, lab-style branding with injectable vials, and bodybuilding or tanning marketing. It also says “Legitimate sellers will often require a buyer to first contact them.”
So operating as RUO, in practice, means:
- Selling to qualified buyers, with a qualification step before purchase
- No human-use marketing anywhere: site, social, email, packaging inserts, support replies
- No dosing content, no reconstitution calculators, no personal-use guides
- No bacteriostatic water or syringes bundled or sold alongside
- No before/after content, no testimonials about effects, no gym, tanning or anti-aging angles
One more thing people get wrong. The 2026 compounding news (the April removals from FDA’s Category 2 list and the July advisory committee votes) is advisory or procedural. Nothing changes without a final rule, and compounding needs pharmaceutical-grade API and a prescription anyway. Research-grade product can’t be used for it. 2026 didn’t make peptides “legal.”
If your business plan only works with human-use marketing, don’t start it. We’d rather tell you that now than after a warning letter.
Step 2: entity, counsel and a written compliance position
Form the company, open a business bank account that’s used for nothing else, and get your tax registration sorted before you buy inventory. Then book time with a lawyer who knows FDA and FTC rules, before you spend money on a site or stock. This is the cheapest point in the whole process to get the model right.
Come out of that conversation with a one-page compliance position: who your customers are, how you qualify them, what you will and won’t say about products, and what you won’t sell. Underwriters ask versions of these questions, and having the answers in writing makes every later step faster.
Step 3: supplier and COA chain
Your certificate of analysis (COA) chain is the backbone of an RUO business, so vet suppliers on testing before price. A useful peptide COA shows the product name, label claim, vendor name, batch or lot, the date the lab received the sample, HPLC purity, mass spec identity, quantity, test date, and the lab’s name, accreditation and signature.
What to insist on:
- Third-party testing by a lab independent of the vendor. A COA without a vendor name or batch ID is worthless.
- Batch matching. The lot on the COA has to match the lot on the vial.
- Verifiable originals. Ask for a link to the lab’s record rather than a PDF, because PDFs can be edited. Some labs offer verification; Janoshik’s, for example, takes a task number and a unique key.
Minimum orders vary a lot. One overseas supplier we’ve seen lists a minimum of a single box of 10 vials with custom labels available, while general consumer-goods white-label minimums run far higher. If you’re weighing that choice, our post on white label vs private label peptides covers the trade-offs.
Step 4: brand, labels and packaging
Brand after the compliance position, not before, because the brand has to fit it. Lab-supplier branding works; gym, tanning and transformation imagery is exactly what processors are told to flag.
Labels carry the product name, strength or quantity, lot number, storage instructions and a research-use-only statement that actually describes how you sell the product. They leave off dosing, benefit words and anything implying human use. Our peptide vial label guide goes through sizes, materials and a must-have checklist. Don’t commit to a big print run until the site, the COA library and the labels all use the same product names and lot format.
Step 5: a domain and site built to pass underwriting
Register the domain early, at a registrar you control. Then build the site for two readers: a buyer and an underwriter. Both want the same things: a real company with a real address and phone number, clear refund, shipping, privacy and terms pages, product pages that list specifications rather than effects, a COA library tied to batches, and a buyer qualification step.
Which platform? We’ve written up whether you can sell peptides on Shopify and how it compares with WooCommerce. Short version: Shopify Payments is off the table, and the gateway you can get approved for may decide the platform for you.
Step 6: payments, applied for before launch
Apply for card processing while the site is in staging, not after you’ve launched. You’ll need a high-risk merchant account, and the honest picture for RUO sellers is a narrow one. Some processors that publicly advertise peptide accounts say they require LegitScript certification (Corepay and Easy Pay Direct both say so), and Corepay states plainly: “We do not support research-use-only (RUO) peptide sellers.” LegitScript’s Healthcare Certification is aimed at pharmacies, telehealth, clinics and similar healthcare merchants. No source we’ve found says an RUO seller can get it.
That leaves acquirers that underwrite RUO businesses on their own terms, and they price the risk. One peptide-focused marketplace describes reserves of “5% to 10% of sales, held 120 to 180 days,” with card rates around 3.5 to 5%. Treat those as typical, not promised. Anyone offering to code you as supplements to get you approved is offering you a future account termination; walk away.
Step 7: shipping, storage and fulfillment
Follow your supplier’s storage specification from receipt to dispatch, and decide upfront whether orders need cold packs and insulated packaging. Read your carrier’s terms for your product class, buy tracking and insurance, and be realistic about international orders, where customs holds and seizures turn into refunds and disputes.
Packing slips and inserts follow the same rules as the site. No dosing cards, no syringes, no “how to use” leaflets.
Step 8: SEO, email and bookkeeping
Set up Search Console on day one and build the pages that earn search traffic without claims: brand pages, product pages with specs, and COA and batch pages. People really do search “[compound] coa” and “hplc tested peptides.”
For email, read the acceptable use policy before you import a single address. Omnisend’s policy prohibits prescription medications “including but not limited to drugs for research purposes,” Klaviyo’s prohibits pharmaceutical products, and we haven’t found an email platform that publicly says it accepts research peptides. Ask in writing and keep your list exported.
For bookkeeping, track reserves as a separate line from day one, and keep lot numbers tied to sales so you can answer any batch question in minutes.
Rough timeline and the cash nobody mentions
These are rough planning ranges from our own work, not quotes. Several steps run in parallel.
| Phase | Rough time | What drives the cost |
|---|---|---|
| Entity, counsel, compliance position | 1 to 3 weeks | Lawyer’s rate and how much they review |
| Supplier vetting and first tested batch | 3 to 6 weeks | Minimum order and per-batch third-party testing |
| Brand and labels | 2 to 4 weeks | Design scope, label stock, print run size |
| Site build | 4 to 8 weeks | Platform, COA library, buyer qualification flow |
| Merchant application | Several weeks, varies widely | Underwriting questions, then reserves |
| Shipping setup | 1 to 2 weeks, in parallel | Packaging, cold packs, insurance |
From decision to first card sale, three to four months is a realistic floor. Faster usually means a step got skipped.
The cost founders forget is the reserve. Using the typical terms above, a store doing $20,000 to $50,000 a month in card sales with a 5% to 10% rolling reserve held four to six months will have somewhere between $4,000 and $30,000 sitting with the processor before the first release. Budget for it like inventory.
What we’d skip in the first six months
- Paid ads. Google and Meta policies make this a dead end for most peptide catalogs.
- A big catalog. Ten well-documented SKUs with clean COAs beat fifty with gaps.
- Subscriptions. Recurring billing adds its own card-network scrutiny on top of an already high-risk account.
- Affiliates and influencers. You’re responsible for what they say, and their statements count as evidence of intended use.
- “Benefits” content, calculators and guides. These are what the August 2026 letters cited.
- A second storefront. Get one business clean before you multiply it.
What we’d do this week
Book the lawyer. Write the one-page compliance position. Ask two or three suppliers for COAs with verification links and see who answers properly. Register the domain. Everything else follows from those four.
We work with research suppliers who want to run a clean, defensible business, and with clinics and telehealth brands that can qualify for certification. We don’t help anyone dress up human-use sales as research. If you want one team to handle the site, labels and payments in the order above, that’s what Peptide Marketing HQ does.
FAQ
Is it legal to sell research peptides online?
It depends on how you operate, and that’s a question for a lawyer who knows FDA and FTC rules. What’s clear from the warning letters is that an RUO label doesn’t protect a business whose site, marketing or bundles point to human use. The FDA looks at the whole picture.
Do I need LegitScript certification to start a peptide business?
LegitScript’s Healthcare Certification is aimed at pharmacies, telehealth, clinics and similar businesses, and no source we’ve found says research-use-only sellers are eligible. Some processors require it, which narrows your payment options if you’re RUO. Clinics and telehealth brands should look at certification seriously.
Can I sell bacteriostatic water alongside research peptides?
We’d advise against it. The August 2026 FDA letters specifically cited bacteriostatic water sold alongside peptides as evidence of human use. It’s one of the clearest signals you can send in the wrong direction.
How long does it take to start a research peptide company?
Plan for three to four months from decision to first card sale as a rough floor. Supplier testing, the site build and merchant underwriting take the most time, and payments should be applied for before launch, not after.
